Nigeria has recorded 146 new cases of novel coronavirus, taking the country’s total to 4,787.
959 cases have been discharged and 158 deaths have been recorded in 34 states and the Federal Capital Territory, according to the Nigeria Centre for Disease Control, NCDC.
146 new cases of #COVID19;
57-Lagos
27-Kano
10-Kwara
9-Edo
8-Bauchi
7-Yobe
4-Kebbi
4-Oyo
3-Katsina
3-Niger
2-Plateau
2-Borno
2-Sokoto
2-Benue
1-Gombe
1-Enugu
1-Ebonyi
1-Ogun
1-FCT
1-Rivers4787 cases of #COVID19 in Nigeria
Discharged: 959
Deaths: 158 pic.twitter.com/vlqzSxqacq— NCDC (@NCDCgov) May 12, 2020
The new cases were confirmed in Lagos, Kano, Kwara, Edo, Bauchi, Yobe and 14 others.
The 146 new cases are reported from 20 states- Lagos(57), Kano(27), Kwara(10), Edo(9), Bauchi(8), Yobe(7), Kebbi(4), Oyo(4), Katsina(3), Niger(3), Plateau(2), Borno(2), Benue(2), Sokoto(2), Gombe(1), Enugu(1), Ebonyi(1), Ogun(1), FCT(1), Rivers(1)
Meanwhile the Federal Government has said that the Madagascar herbal remedy for COVID-19 will be subjected to the normal regulatory processes before it can be administered for use in Nigeria.
The National Coordinator, Presidential Task Force (PTF) on the COVID-19, Dr. Sani Aliyu, said this on Tuesday in Abuja at the 30th joint national briefing of the taskforce.
According to him, following the presidential directive that the herbal remedy be airlifted to Nigeria, it will be subjected to thr stringent regulatory process within the legal frameworks of the country concerning such circumstance.
President Muhammadu Buhari, had ordered the airlift of the Madagascar herbal medicine for the prevention and treatment of COVID-19 from Guinea Bissau where Nigeria’s portions were dispatched to for onward delivery to Nigeria.
“I want to start briefly by talking about the Madagascar cure. As directed by the President, I want to state that any medication coming into the country whether it is herbal cure or concoction or normal drug. It has to be subjected to the normal regulatory process.
“The Madagascar cure will be subjected to the normal process we expect within the legal frameworks and guidelines that we have. More importantly, not only to establish its efficacy but for it to be legally registered.
“So this drug would go through the normal regulatory process which can be stringent before it can be administered in the country,” Aliyu said.
